Quality of Life — Quality of Life Related to Digestive Symptoms After Cholecistectomy. Short Term Effects of a Low Fat Intake.
Citation(s)
Altomare DF, Rotelli MT, Palasciano N Diet after cholecystectomy. Curr Med Chem. 2017 May 17. doi: 10.2174/0929867324666170518100053. [Epub ahead of print]
Marcason W What medical nutrition therapy guideline is recommended post-cholecystectomy? J Acad Nutr Diet. 2014 Jul;114(7):1136. doi: 10.1016/j.jand.2014.05.009.
Phillips SF Diarrhea after cholecystectomy: if so, why? Gastroenterology. 1996 Sep;111(3):816-8.
Plaisier PW Cholecystectomy and bowel function. Gut. 2001 Feb;48(2):283.
Ros E, Zambon D Postcholecystectomy symptoms. A prospective study of gall stone patients before and two years after surgery. Gut. 1987 Nov;28(11):1500-4.
Shin Y, Choi D, Lee KG, Choi HS, Park Y Association between dietary intake and postlaparoscopic cholecystectomic symptoms in patients with gallbladder disease. Korean J Intern Med. 2018 Jul;33(4):829-836. doi: 10.3904/kjim.2016.223. Epub 2017 Nov 10.
Talseth A, Edna TH, Hveem K, Lydersen S, Ness-Jensen E Quality of life and psychological and gastrointestinal symptoms after cholecystectomy: a population-based cohort study. BMJ Open Gastroenterol. 2017 Apr 1;4(1):e000128. doi: 10.1136/bmjgast-2016-0001
Tan VP The low-FODMAP diet in the management of functional dyspepsia in East and Southeast Asia. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:46-52. doi: 10.1111/jgh.13697. Review.
Wilson RG, Macintyre IM Symptomatic outcome after laparoscopic cholecystectomy. Br J Surg. 1993 Apr;80(4):439-41.
Yueh TP, Chen FY, Lin TE, Chuang MT Diarrhea after laparoscopic cholecystectomy: associated factors and predictors. Asian J Surg. 2014 Oct;37(4):171-7. doi: 10.1016/j.asjsur.2014.01.008. Epub 2014 Mar 17.
Quality of Life Related to Digestive Symptoms After Cholecistectomy. Short Term Effects of a Low Fat Intake.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
